Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males
NCT06542237
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
88
Enrollment
INDUSTRY
Sponsor class
Conditions
Male Contraception
Interventions
DRUG:
YCT-529
Sponsor
YourChoice Therapeutics, Inc.